S1 Ep161: Highlighting Advancements in Personalized T-Cell Lymphoma Treatment
In a conversation with CancerNetwork®, Viviana Cortiana, MS4, medical student in the Department of Medical and Surgical Sciences at the University of Bologna, and Yan Leyfman, MD, a resident physician from the Icahn School of Medicine of the Mount Sinai Health System, discussed their publication in the March 2025 issue of ONCOLOGY (https://www.cancernetwork.com/view/expanding-horizons-in-t-cell...
18m May 12, 2025
18m
S1 Ep160: Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia
Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.
24m May 05, 2025
24m
S1 Ep159: Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors
In an interview with CancerNetwork®, William Kennedy, MD, a neuro-radiation oncologist at the Ivy Brain Tumor Center, provided expert insights into the current state of radiosurgery for central nervous system (CNS) tumors. Highlighting a diverse array of available radiosurgery platforms, he explained that institutions like the Ivy Brain Tumor Center frequently use noninvasive surgical technique...
16m Apr 28, 2025
16m
S1 Ep158: Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.
15m Apr 21, 2025
15m
S1 Ep157: Fostering The Future of Psychosocial Care With World Psycho-Oncology Day
The International Psycho-Oncology Society (IPOS) deemed April 9th, 2025, the first-ever World Psycho-Oncology Day (WPOD). This day was meant to spread awareness of the importance of prioritizing psychosocial care for patients with all types of cancer as well as to honor Jimmie C. Holland, MD. Prior to WPOD, CancerNetwork® spoke with Cristiane Decat Bergerot, PhD, BS, MS, a psychologist and the...
9m Apr 14, 2025
9m
S1 Ep156: Elevating the Quality of Cancer Care Via Cross-Department Collaboration
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
13m Apr 07, 2025
13m
S1 Ep155: Improving NSCLC Surgery Recovery After Climate Disaster Exposure
The “inescapability” of climate hazards may necessitate prioritization of research to improve outcomes among vulnerable populations who require treatment.
11m Mar 31, 2025
11m
S1 Ep154: Considering Dosing and AE Management Strategies With Tarlatamab in SCLC
Experts from Washington University in St. Louis discuss prior data and strategies for mitigating toxicities like CRS associated with tarlatamab in SCLC.
22m Mar 24, 2025
22m
S1 Ep153: Redefining the Treatment Paradigm in Low Grade Serous Ovarian Cancer
Molecular differences in the profiles of low grade serous ovarian cancer (LGSOC) and high-grade SOC substantiate the need to find unique, differentiated treatment options for each epithelial ovarian cancer subtype, according to Kathleen N. Moore, MD, MS. CancerNetwork® spoke with Moore, Virginia Kerley Cade Endowed Chair of Cancer Development, associate director of Clinical Research at the Ste...
31m Mar 17, 2025
31m
S1 Ep152: Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care
In a recent episode of Oncology on the Go, several oncologists discussed the impact of the COVID-19 pandemic on oncology care, 5 years later. Each doctor discussed a different aspect of multidisciplinary care, including medical oncology, radiation oncology, and epidemiology. CancerNetwork® spoke with leading clinicians including: ·      Aditya Bardia, MD, MPH, FSCO, professor in the Departmen...
12m Mar 10, 2025
12m
S1 Ep151: Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting
CancerNetwork®, in collaboration with The American Society for Transplantation and Cellular Therapy (ASTCT), organized an X Space hosted by Rahul Banerjee, MD, FACP, an assistant Professor in the Clinical Research Division at the Fred Hutchinson Cancer Center in Seattle, Washington, and Shernan Holtan, MD, the chief of Blood and Marrow Transplantation and professor of Medicine at Roswell Park C...
57m Mar 03, 2025
57m
S1 Ep150: Sotorasib Combo Approval May Address Novel Therapy Need in KRAS G12C+ CRC
The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.
10m Feb 24, 2025
10m
S1 Ep149: Highlighting Insights From the Marginal Zone Lymphoma Workshop
Following the 2024 Marginal Zone Lymphoma (MZL) Workshop, CancerNetwork® spoke with multiple attending clinicians about insights they shared regarding the disease state, covering the significance of the workshop and its contribution to advancing research in areas such as prognostic factors and managing adverse events (AEs) related to the disease. Thomas Habermann, MD, professor of Medicine at ...
12m Feb 17, 2025
12m
S1 Ep148: Navigating Management and Dosing Considerations for Amivantamab in NSCLC
Experts from Washington University in St. Louis discuss trial results and infusion-related reaction management for amivantamab in EGFR-mutated NSCLC.
27m Feb 10, 2025
27m
S1 Ep147: Expanding and Advancing the Future of Renal Cell Carcinoma Treatment
In collaboration with KidneyCAN, CancerNetwork® spoke with Eric Jonasch, MD, a professor in the Department of Genitourinary Medical Oncology of the Division of Cancer Medicine, and the director of the von Hippel Lindau Center at the University of Texas MD Anderson Cancer Center in Houston, Texas, about the missions and goals of the Kidney Cancer Research Consortium. Jonasch is the principal in...
18m Feb 03, 2025
18m
S1 Ep146: Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology
Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.
11m Jan 27, 2025
11m
S1 Ep145: Psilocybin May Help Address Cancer-Related Psychological Concerns
CancerNetwork® spoke with Michael P. Bogenschutz, MD, director of the NYU Langone Center for Psychedelic Medicine and professor of Psychiatry at NYU Grossman School of Medicine, about psilocybin-assisted psychotherapy (PAP) in managing psychological challenges associated with serious cancer diagnoses following the publication of a pooled analysis of 2 phase 2 trials (https://www.cancernetwork.c...
16m Jan 20, 2025
16m
S1 Ep144: SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care
Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.
41m Jan 13, 2025
41m
S1 Ep143: Using Multidisciplinary Lifestyle Medicine to Enhance Cancer Survivor QOL
Authors of an article published in ONCOLOGY® detail how a novel multidisciplinary lifestyle medicine clinic can meet the needs of cancer survivors.
33m Jan 06, 2025
33m
S1 Ep142: Determining Suitable Radioligand Therapy Use in Neuroendocrine Tumors
Oncologists discuss data from the NETTER-1 and NETTER-2 trials and the extent to which they support the applicability of 177Lu-dotatate in NETs.
19m Dec 30, 2024
19m
S1 Ep141: Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations
CancerNetwork® spoke with Rachel A. Greenup, MD, MPH, an associate professor of surgery (oncology), section chief of Breast Surgery, and co-director of the Center for Breast Cancer at the Yale School of Medicine, about the rationale behind conducting a study evaluating the lived experiences among women of color following breast cancer mastectomy (https://www.cancernetwork.com/view/study-shows-p...
9m Dec 23, 2024
9m
S1 Ep140: Highlighting Advocacy Impacts on Funding for Kidney Cancer Research
CancerNetwork, in a partnership with KidneyCAN, spoke with 2 genitourinary oncologists, Elizabeth P. Henske, MD, and Jason Muhitch, PhD, about how advocacy and funding through interdisciplinary collaboration between patient advocates, researchers, and physicians have resulted in numerous clinical breakthroughs in kidney cancer. Henske is a professor of medicine at the Harvard Medical School, a...
12m Dec 16, 2024
12m
S1 Ep139: Ensuring Holistic, Individualized Transitions of Care for Cancer Survivors
Andrew M. Evens, DO, MBA, MSc, discusses the importance of meeting the emotional and physical needs of cancer survivors to help them lead fruitful lives.
17m Dec 09, 2024
17m
S1 Ep138: Managing Risks, Planning Treatment, & Making Progress in Pancreatic Cancer
During Pancreatic Cancer Awareness Month (https://www.cancernetwork.com/awareness-month/pancreatic-cancer-awareness-month) , CancerNetwork® spoke with Kelly A. Rone, DNP, RN, AGNP-c, about the current state of pancreatic cancer, emphasizing risk factors, diagnostic challenges, and treatment planning. Rone is an advanced practice nurse of gastrointestinal oncology at Mayo Clinic in Phoenix, Ariz...
25m Dec 02, 2024
25m
S1 Ep137: Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.
29m Nov 25, 2024
29m
S1 Ep136: Collaboration Fosters Treatment Advancements for Young Lymphoma Populations
A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.
21m Nov 18, 2024
21m
S1 Ep135: Educating Patients and Clinicians on End-of-Life Care and Discussions
Kelley A. Rone, DNP, RN, AGNP-c, provides perspective on approaching end-of-life conversations with patients with GI cancers.
19m Nov 11, 2024
19m
S1 Ep134: Uterine Transposition May Maintain Fertility Following Pelvic Radiotherapy
CancerNetwork® spoke with John Paul Diaz, MD, about uterine transposition, a surgical technique aiming to preserve fertility in women undergoing radiotherapy for pelvic tumors. Diaz is the chief of gynecologic oncology, director of robotic surgery, director of the Center of Excellence in Minimally Invasive Gynecologic Surgery at Baptist Health, and lead physician for Clinical Trials in Gynecolo...
13m Nov 04, 2024
13m
S1 Ep133: Empowering Awareness to Address Rising Gynecological Cancer Incidence
Ginger J. Gardner, MD, FACOG, highlights disease prevention innovations and other ongoing efforts to empower education in the gynecologic cancer field.
20m Oct 28, 2024
20m
S1 Ep132: Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
A panel of expert pharmacists provides their perspectives on gene therapy agents such as exagamglogene autotemcel in the management of sickle cell disease.
48m Oct 21, 2024
48m
S1 Ep131: Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma
CancerNetwork® collaborated with CURE® to speak with Samantha Shenoy, NP, MSN, a nurse practitioner at the Cancer Immunotherapy Clinic of University of California San Francisco (UCSF) Health, about the role she plays when treating patients with multiple myeloma who are receiving talquetamab-tgvs (Talvey). Of note, emphasis was placed on managing treatment-emergent adverse effects (TRAEs) and to...
21m Oct 14, 2024
21m
S1 Ep130: Forming Connections and Making a Difference in the Brain Cancer Field
The only way forward in the brain cancer field is to be open to mentoring others, according to Yoshie Umemura, MD.
20m Oct 07, 2024
20m
S1 Ep129: Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma
James R. Berenson, MD, describes ongoing efforts to evaluate treatment with JAK inhibitors like ruxolitinib among patients with multiple myeloma.
16m Sep 30, 2024
16m
S1 Ep128: Advancing Glioblastoma Research Through a Phase 3 Niraparib Trial
Investigators of the Gliofocus trial look to set a clinically relevant “benchmark” in the glioblastoma field, according to Nader Sanai, MD.
20m Sep 23, 2024
20m
S1 Ep127: Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs
Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.
8m Sep 16, 2024
8m
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation
Jessica Cheng, MD, highlights how physical medicine and rehabilitation may help optimize function and performance status in patients with cancer.
19m Sep 09, 2024
19m
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
Experts in multiple myeloma weigh the benefits and risks of administering CAR T-cell therapy to patients based on prior reports of secondary malignancies.
18m Sep 02, 2024
18m
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
Brian A. Van Tine, MD, PhD, discusses potential evolutions in the treatment landscape following the FDA approval of afami-cel in metastatic synovial sarcoma.
12m Aug 26, 2024
12m
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel (https://www.cancernetwork.com/view/fda-expands-approval-for-dostarlimab-chemo-in-advanced-endometrial-cancer) for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gy...
11m Aug 19, 2024
11m
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
Cancer vaccines may pair well with other forms of immunotherapy in the treatment of patients with cancer, according to Catherine J. Wu, MD.
14m Aug 12, 2024
14m
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
Experts from Vanderbilt Medical Center review mechanisms, supporting data, and patient cases associated with the use of IORT in pancreatic cancer.
28m Aug 05, 2024
28m
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
Nausheen Ahmed, MD, discusses findings from a study supporting reduced monitoring windows for patients with lymphoma who receive CAR T-cell therapy.
16m Jul 29, 2024
16m
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.
10m Jul 22, 2024
10m
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.
19m Jul 15, 2024
19m
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
Bispecific antibodies including epcoritamab have “a lot of potential for upward mobility” in lymphoma, according to Tycel Phillips, MD.
13m Jul 08, 2024
13m
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
AI tools may show utility in areas such as prostate diagnostic imaging, pathology, and treatment outcome predictions.
32m Jul 01, 2024
32m
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024
Experts discuss updated findings presented at the 2024 EHA Congress in diseases such as mantle cell lymphoma and acute myeloid leukemia.
8m Jun 24, 2024
8m
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice
Following the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, (https://www.cancernetwork.com/conference/asco) Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field. Iyengar is an associate attending physician at Memorial Sloan Kettering Canc...
31m Jun 17, 2024
31m
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval
In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). The FDA previously approved fruquintinib as a t...
14m Jun 10, 2024
14m
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
In a conversation with CancerNetwork®, Terence T. Sio, MD, MS, discussed how technological advancements in radiation oncology have impacted the modern treatment landscape for patients with non–small cell lung cancer (NSCLC). Sio, a professor of radiation oncology at Mayo Clinic in Phoenix, Arizona, first outlined the use of immunotherapy and other systemic treatment options for this patient po...
27m Jun 03, 2024
27m